Lars Mäegdefessel
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases
- Phagocytosis and Immune Regulation
Papers in
-
- MicroRNA in disease regulation 35
- Cancer-related molecular mechanisms research 34
-
- Venous Thromboembolism Diagnosis and Management 11
- Co-authors
- Philip S. TsaoNicholas J. LeeperJoshua M. SpinUlf HedinJunya AzumaUwe RaazRonald L. DalmanLjubica Matic
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (21 papers)Atherosclerosis (12 papers)Cardiovascular Research (9 papers)Thrombosis and Haemostasis (7 papers)Circulation (6 papers)
- Partner nations
- GermanySwedenUnited States
In The Last Decade
Lars Mäegdefessel
154 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 1.8k
- Immunology 1.5k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 2.7k
- Cardiology and Cardiovascular Medicine 866
Countries citing papers authored by Lars Mäegdefessel
This map shows the geographic impact of Lars Mäegdefessel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Mäegdefessel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Mäegdefessel more than expected).
Fields of papers citing papers by Lars Mäegdefessel
This network shows the impact of papers produced by Lars Mäegdefessel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Mäegdefessel. The network helps show where Lars Mäegdefessel may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Mäegdefessel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 44 | |
| 5 | 2024 | 35 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 42 | |
| 14 | 2022 | 16 | |
| 15 | 2021 | 72 | |
| 16 | 2021 | 42 | |
| 17 | 2021 | 70 | |
| 18 | 2016 | 32 | |
| 19 | 2014 | 116 | |
| 20 | 2012 | 3 |
About Lars Mäegdefessel
Lars Mäegdefessel is a scholar working on Cancer Research, Internal Medicine, Immunology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 163 papers that have together received 5.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (35 papers), Aortic aneurysm repair treatments (34 papers), Cancer-related molecular mechanisms research (34 papers), Atherosclerosis and Cardiovascular Diseases (30 papers), Aortic Disease and Treatment Approaches (26 papers), Circular RNAs in diseases (26 papers), Infectious Aortic and Vascular Conditions (15 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). The work is most often cited by research in Cancer Research (1.8k citations), Immunology (1.5k citations), Pulmonary and Respiratory Medicine (1.4k citations), Molecular Biology (2.7k citations) and Cardiology and Cardiovascular Medicine (866 citations). Lars Mäegdefessel has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Philip S. Tsao, Nicholas J. Leeper, Joshua M. Spin, Ulf Hedin, Junya Azuma, Uwe Raaz, Ronald L. Dalman, Ljubica Matic, Thomas Quertermous and Yoko Kojima. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Atherosclerosis, Cardiovascular Research, Thrombosis and Haemostasis and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.